{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T12:50:52Z","timestamp":1773233452505,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2012,2,14]],"date-time":"2012-02-14T00:00:00Z","timestamp":1329177600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Orthopaedics (SICOT)"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1007\/s00264-012-1497-6","type":"journal-article","created":{"date-parts":[[2012,2,13]],"date-time":"2012-02-13T05:09:31Z","timestamp":1329109771000},"page":"1523-1528","source":"Crossref","is-referenced-by-count":29,"title":["Effect of pentoxifylline on histopathological changes in steroid-induced osteonecrosis of femoral head: experimental study in chicken"],"prefix":"10.1007","volume":"36","author":[{"given":"H. Yener","family":"Erken","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Onder","family":"Ofluoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Aktas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cumhur","family":"Topal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muzaffer","family":"Yildiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,2,14]]},"reference":[{"issue":"1","key":"1497_CR1","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.arth.2007.01.006","volume":"23","author":"JR Lieberman","year":"2008","unstructured":"Lieberman JR, Roth KM, Elsissy P et al (2008) Symptomatic osteonecrosis of the hip and knee after cardiac transplantation. J Arthroplasty 23(1):90\u201396","journal-title":"J Arthroplasty"},{"issue":"5","key":"1497_CR2","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1080\/17453670810016641","volume":"79","author":"M Shibatani","year":"2008","unstructured":"Shibatani M, Fujioka M, Arai Y et al (2008) Degree of corticosteroid treatment within the first 2\u00a0months of renal transplantation has a strong influence on the incidence of osteonecrosis of the femoral head. Acta Orthop 79(5):631\u2013636","journal-title":"Acta Orthop"},{"issue":"5","key":"1497_CR3","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1191\/0961203305lu2103oa","volume":"14","author":"K Nagasawa","year":"2005","unstructured":"Nagasawa K, Tada Y, Koarada S et al (2005) Very early development of steroid-associated osteonecrosis of femoral head in systemic lupus erythematosus: prospective study by MRI. Lupus 14(5):385\u2013390","journal-title":"Lupus"},{"key":"1497_CR4","doi-asserted-by":"crossref","unstructured":"Weinstein RS (2011) Glucocorticoid-induced osteonecrosis. Endocrine Dec 15. [Epub ahead of print]","DOI":"10.1007\/s12020-011-9580-0"},{"issue":"3\u20135","key":"1497_CR5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jsbmb.2009.02.007","volume":"114","author":"MA Kerachian","year":"2009","unstructured":"Kerachian MA, S\u00e9guin C, Harvey EJ (2009) Glucocorticoids in osteonecrosis of the femoral head: a new understanding of the mechanisms of action. J Steroid Biochem Mol Biol 114(3\u20135):121\u2013128","journal-title":"J Steroid Biochem Mol Biol"},{"key":"1497_CR6","first-page":"68","volume":"130","author":"DE Fisher","year":"1978","unstructured":"Fisher DE (1978) The role of fat embolism in the etiology of corticosteroid-induced avascular necrosis: clinical and experimental results. Clin Orthop Relat Res 130:68\u201380","journal-title":"Clin Orthop Relat Res"},{"key":"1497_CR7","first-page":"30","volume-title":"Bone circulation","author":"LC Jones","year":"1984","unstructured":"Jones LC, Hungerford DS (1984) Models of ischemic necrosis of bone. In: Arlet J, Ficat RP, Hungerford DS (eds) Bone circulation. Williams and Wilkins, Baltimore, pp 30\u201334"},{"key":"1497_CR8","first-page":"263","volume":"8","author":"K Kawai","year":"1983","unstructured":"Kawai K, Maruno H, Hirohata K (1983) Fat necrosis of osteocytes as a causative factor in idiopathic osteonecrosis of the femoral head in man. Trans Orthop Res Soc 8:263","journal-title":"Trans Orthop Res Soc"},{"key":"1497_CR9","doi-asserted-by":"crossref","first-page":"729","DOI":"10.2106\/00004623-197759060-00003","volume":"59A","author":"GJ Wang","year":"1977","unstructured":"Wang GJ, Sweet DE, Reger SI et al (1977) Fatcell changes as a mechanism of avascular necrosis of the femoral head in cortisone-treated rabbits. J Bone Joint Surg 59A:729\u2013735","journal-title":"J Bone Joint Surg"},{"key":"1497_CR10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-4-431-68192-2_8","volume-title":"Trends in research and treatment of joint diseases","author":"GJ Wang","year":"1992","unstructured":"Wang GJ (1992) Pathogenesis of steroid-induced avascular necrosis and its response to lipid clearing agent. In: Hirohata K, Mizuno K, Matsubara T (eds) Trends in research and treatment of joint diseases. Springer-Verlag, Tokyo, pp 59\u201371"},{"key":"1497_CR11","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00003086-200001000-00030","volume":"370","author":"GJ Wang","year":"2000","unstructured":"Wang GJ, Cui Q, Balian G (2000) The Nicolas Andry award. The pathogenesis and prevention of steroid induced osteonecrosis. Clin Orthop Relat Res 370:295\u2013310","journal-title":"Clin Orthop Relat Res"},{"key":"1497_CR12","first-page":"35","volume-title":"Bone circulation","author":"GJ Wang","year":"1984","unstructured":"Wang GJ, Dughman SS, Reger SI (1984) Femoral head blood flow in long- term steroid treatment (study of rabbit model). In: Arlet J, Ficat RP, Hungerford DS (eds) Bone circulation. Williams and Wilkins, Baltimore, pp 35\u201337"},{"issue":"6","key":"1497_CR13","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.jbspin.2007.12.008","volume":"75","author":"K Pengde","year":"2008","unstructured":"Pengde K, Fuxing P, Bin S et al (2008) Lovastatin inhibits adipogenesis and prevents osteonecrosis in steroid-treated rabbits. Joint Bone Spine 75(6):696\u2013701","journal-title":"Joint Bone Spine"},{"issue":"10","key":"1497_CR14","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1093\/rheumatology\/keh721","volume":"44","author":"T Kabata","year":"2005","unstructured":"Kabata T, Kubo T, Matsumoto T et al (2005) Onset of steroid-induced osteonecrosis in rabbits and its relationship to hyperlipaemia and increased free fatty acids. Rheumatology 44(10):1233\u20131237","journal-title":"Rheumatology"},{"key":"1497_CR15","first-page":"8","volume":"344","author":"Q Cui","year":"1997","unstructured":"Cui Q, Wang GJ, Su CC et al (1997) The Otto Aufranc award. Lovastatin prevents steroid induced adipogenesis and osteonecrosis. Clin Orthop Relat Res 344:8\u201319","journal-title":"Clin Orthop Relat Res"},{"key":"1497_CR16","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00003086-200105000-00022","volume":"386","author":"JW Pritchett","year":"2001","unstructured":"Pritchett JW (2001) Statin therapy decreases the risk of osteonecrosis in patients with receiving steroids. Clin Orthop Relat Res 386:173\u2013178","journal-title":"Clin Orthop Relat Res"},{"key":"1497_CR17","first-page":"81","volume":"130","author":"GJ Wang","year":"1978","unstructured":"Wang GJ, Moga DB, Richemer WG et al (1978) Cortisone induced bone changes and its response to lipid clearing agents. Clin Orthop Relat Res 130:81\u201385","journal-title":"Clin Orthop Relat Res"},{"issue":"3","key":"1497_CR18","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2613.2010.00705.x","volume":"91","author":"P Kang","year":"2010","unstructured":"Kang P, Gao H, Pei F et al (2010) Effects of an anticoagulant and a lipid-lowering agent on the prevention of steroid-induced osteonecrosis in rabbits. Int J Exp Pathol 91(3):235\u2013243","journal-title":"Int J Exp Pathol"},{"issue":"12","key":"1497_CR19","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.3899\/jrheum.080416","volume":"35","author":"G Motomura","year":"2008","unstructured":"Motomura G, Yamamoto T, Miyanishi K et al (2008) Risk factors for developing osteonecrosis after prophylaxis in steroid-treated rabbits. J Rheumatol 35(12):2391\u20132394","journal-title":"J Rheumatol"},{"issue":"5","key":"1497_CR20","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1007\/s11999-008-0189-4","volume":"466","author":"K Nishida","year":"2008","unstructured":"Nishida K, Yamamoto T, Motomura G et al (2008) Pitavastatin may reduce risk of steroid-induced osteonecrosis in rabbits: a preliminary histological study. Clin Orthop Relat Res 466(5):1054\u20131058","journal-title":"Clin Orthop Relat Res"},{"issue":"8","key":"1497_CR21","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1302\/0301-620X.86B8.14834","volume":"86","author":"JD Calder","year":"2004","unstructured":"Calder JD, Buttery L, Revell PA et al (2004) Apoptosis\u2014a significant cause of bone cell death in osteonecrosis of the femoral head. J Bone Joint Surg Br 86(8):1209\u20131213","journal-title":"J Bone Joint Surg Br"},{"issue":"8","key":"1497_CR22","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1210\/jc.85.8.2907","volume":"85","author":"JD Calder","year":"2000","unstructured":"Calder JD, Buttery L, Revell PA et al (2000) Apoptosis of osteocytes in glucocorticoid-induced osteonecrosis of the hip. J Clin Endocrinol Metab 85(8):2907\u20132912","journal-title":"J Clin Endocrinol Metab"},{"issue":"2\u20134","key":"1497_CR23","first-page":"221","volume":"13","author":"C Zalavras","year":"2003","unstructured":"Zalavras C, Shah S, Birnbaum MJ et al (2003) Role of apoptosis in glucocorticoid-induced osteoporosis and osteonecrosis. Crit Rev Eukaryot Gene Expr 13(2\u20134):221\u2013235","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"1497_CR24","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2165\/00003495-198734010-00003","volume":"34","author":"A Ward","year":"1987","unstructured":"Ward A, Clissold SP (1987) Pentoxifylline: a review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy. Drugs 34:50\u201397","journal-title":"Drugs"},{"issue":"2","key":"1497_CR25","first-page":"103","volume":"9","author":"M Zhang","year":"2004","unstructured":"Zhang M, Xu YJ, Mengi SA et al (2004) Therapeutic potentials of pentoxifylline for treatment of cardiovascular diseases. Exp Clin Cardiol 9(2):103\u2013111","journal-title":"Exp Clin Cardiol"},{"issue":"6","key":"1497_CR26","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/jor.1100180602","volume":"18","author":"EM Schwarz","year":"2000","unstructured":"Schwarz EM, Benz EB, Lu AP et al (2000) Quantitative small-animal surrogate to evaluate drug efficacy in preventing wear debris-induced osteolysis. J Orthop Res 18(6):849\u2013855","journal-title":"J Orthop Res"},{"issue":"3","key":"1497_CR27","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S8756-3282(00)00450-6","volume":"28","author":"H Horiuchi","year":"2001","unstructured":"Horiuchi H, Saito N, Kinoshita T et al (2001) Enhancement of bone morphogenetic protein-2-induced new bone formation in mice by the phosphodiesterase inhibitor pentoxifylline. Bone 28(3):290\u2013294","journal-title":"Bone"},{"issue":"11","key":"1497_CR28","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.1210\/en.142.11.4673","volume":"142","author":"G Rawadi","year":"2001","unstructured":"Rawadi G, Ferrer C, Spinella-Jaegle S et al (2001) 1-(5-oxohexyl)-3,7-dimethylxanthine, a phosphodiesterase inhibitor, activates MAPK cascades and promotes osteoblast differentiation by a mechanism independent of PKA activation (pentoxifylline promotes osteoblast differentiation). Endocrinology 142(11):4673\u20134682","journal-title":"Endocrinology"},{"key":"1497_CR29","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S8756-3282(00)00395-1","volume":"27","author":"T Kinoshita","year":"2000","unstructured":"Kinoshita T, Ebara S, Kamimura M et al (2000) Phosphodiesterase inhibitors, Pentoxifylline and Rolipam, increase bone mass by promoting bone formation in normal mice. Bone 27:811\u2013817","journal-title":"Bone"},{"issue":"4","key":"1497_CR30","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00774-003-0490-y","volume":"22","author":"H Horiuchi","year":"2004","unstructured":"Horiuchi H, Saito N, Kinoshita T et al (2004) Enhancement of recombinant human bone morphogenetic protein-2 (rhBMP-2)-induced new bone formation by concurrent treatment with parathyroid hormone and a phosphodiesterase inhibitor, pentoxifylline. J Bone Miner Metab 22(4):329\u2013334","journal-title":"J Bone Miner Metab"},{"issue":"1","key":"1497_CR31","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1667\/0033-7587(2002)157[0062:ROPIPR]2.0.CO;2","volume":"157","author":"DB Pateder","year":"2002","unstructured":"Pateder DB, Sheu TJ, O'Keefe RJ et al (2002) Role of pentoxifylline in preventing radiation damage to epiphyseal growth plate chondrocytes. Radiat Res 157(1):6","journal-title":"Radiat Res"},{"issue":"5","key":"1497_CR32","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.tripleo.2010.05.067","volume":"110","author":"MS Epstein","year":"2010","unstructured":"Epstein MS, Wicknick FW, Epstein JB et al (2010) Management of bisphosphonate-associated osteonecrosis: pentoxifylline and tocopherol in addition to antimicrobial therapy. An initial case series. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 110(5):593\u2013596","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"1497_CR33","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00003086-199204000-00008","volume":"277","author":"M Matsui","year":"1992","unstructured":"Matsui M, Saito S, Ohzono K et al (1992) Experimental steroid-induced osteonecrosis in adult rabbits with hypersensitivity vasculitis. Clin Orthop Relat Res 277:61\u201372","journal-title":"Clin Orthop Relat Res"},{"issue":"6","key":"1497_CR34","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s00264-010-1009-5","volume":"34","author":"YS Gao","year":"2010","unstructured":"Gao YS, Zhang CQ (2010) Cytotherapy of osteonecrosis of the femoral head: a mini review. Int Orthop 34(6):779\u2013782","journal-title":"Int Orthop"},{"issue":"5","key":"1497_CR35","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00264-010-0998-4","volume":"35","author":"M J\u00e4ger","year":"2011","unstructured":"J\u00e4ger M, Zilkens C, Bittersohl B et al (2011) Efficiency of iloprost treatment for osseous malperfusion. Int Orthop 35(5):761\u2013765","journal-title":"Int Orthop"},{"issue":"8","key":"1497_CR36","first-page":"3433","volume":"29","author":"M J\u00e4ger","year":"2009","unstructured":"J\u00e4ger M, Zilkens C, Westhoff B et al (2009) Efficiency of iloprost treatment for chemotherapy-associated osteonecrosis after childhood cancer. Anticancer Res 29(8):3433\u20133440","journal-title":"Anticancer Res"},{"issue":"7","key":"1497_CR37","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1517\/14656566.5.7.1455","volume":"5","author":"G Petje","year":"2004","unstructured":"Petje G, Radler C, Aigner N et al (2004) Pharmacological management of aseptic osteonecrosis in children. Expert Opin Pharmacother 5(7):1455\u20131462","journal-title":"Expert Opin Pharmacother"},{"issue":"6","key":"1497_CR38","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s00264-010-1048-y","volume":"35","author":"T Yoshioka","year":"2011","unstructured":"Yoshioka T, Mishima H, Akaogi H et al (2011) Concentrated autologous bone marrow aspirate transplantation treatment for corticosteroid-induced osteonecrosis of the femoral head in systemic lupus erythematosus. Int Orthop 35(6):823\u2013829","journal-title":"Int Orthop"},{"key":"1497_CR39","doi-asserted-by":"crossref","unstructured":"Gangji V, Hauzeur JP (2005) Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells. Surgical technique. J Bone Joint Surg Am 87 Suppl 1(Pt 1):106\u2013112","DOI":"10.2106\/JBJS.D.02662"},{"issue":"12","key":"1497_CR40","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.3899\/jrheum.080324","volume":"35","author":"G Motomura","year":"2008","unstructured":"Motomura G, Yamamoto T, Irisa T et al (2008) Dose effects of corticosteroids on the development of osteonecrosis in rabbits. J Rheumatol 35(12):2395\u20132399","journal-title":"J Rheumatol"},{"issue":"5","key":"1497_CR41","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jbspin.2007.11.004","volume":"75","author":"X Wu","year":"2008","unstructured":"Wu X, Yang S, Duan D et al (2008) Experimental osteonecrosis induced by a combination of low-dose lipopolysaccharide and high-dose methylprednisolone in rabbits. Joint Bone Spine 75(5):573\u2013578","journal-title":"Joint Bone Spine"},{"issue":"1","key":"1497_CR42","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3109\/17453671003628772","volume":"81","author":"M Kuribayashi","year":"2010","unstructured":"Kuribayashi M, Fujioka M, Takahashi KA et al (2010) Vitamin E prevents steroid-induced osteonecrosis in rabbits. Acta Orthop 81(1):154\u2013160","journal-title":"Acta Orthop"},{"issue":"2","key":"1497_CR43","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00264-008-0672-2","volume":"33","author":"Y Li","year":"2009","unstructured":"Li Y, Han R, Geng C et al (2009) A new osteonecrosis animal model of the femoral head induced by microwave heating and repaired with tissue engineered bone. Int Orthop 33(2):573\u2013580","journal-title":"Int Orthop"},{"issue":"1","key":"1497_CR44","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1302\/0301-620X.89B1.18350","volume":"89","author":"TT Tang","year":"2007","unstructured":"Tang TT, Lu B, Yue B et al (2007) Treatment of osteonecrosis of the femoral head with hBMP-2-gene-modified tissue-engineered bone in goats. J Bone Joint Surg Br 89(1):127\u2013129","journal-title":"J Bone Joint Surg Br"},{"key":"1497_CR45","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1476-5381.1996.tb15450.x","volume":"118","author":"J Sounes","year":"1996","unstructured":"Sounes J, Griffin M, Malslen C et al (1996) Evidence that cyclic AMP phosphodiesterase inhibitors suppress TNF \u03b1 generation from human monocytes by interaction with a low-affinity phosphodiesterase 4 conformer. Br J Pharmacol 118:649\u2013658","journal-title":"Br J Pharmacol"},{"key":"1497_CR46","first-page":"188","volume":"44","author":"AM Badger","year":"1994","unstructured":"Badger AM, Olivera DL, Eser KM (1994) Beneficial effects of the phosphodiesterase inhibitors BRL 61063, pentoxifylline, and rolipram in a murine model of endotoxin shock. Circ Shock 44:188\u2013195","journal-title":"Circ Shock"},{"issue":"6","key":"1497_CR47","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/bjc.1993.489","volume":"68","author":"PL Sensky","year":"1993","unstructured":"Sensky PL, Prise VE, Ward AE et al (1993) The effects of pentoxifylline on the relative perfusion of tumours growing in three sites in the mouse. Br J Cancer 68(6):1110\u20131114","journal-title":"Br J Cancer"},{"key":"1497_CR48","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/8756-3282(91)90071-P","volume":"12","author":"J Hashimato","year":"1991","unstructured":"Hashimato J, Takaoka K, Yoshikawa H et al (1991) Preservation of ectopically induced bone in the mouse by estradiol. Bone 12:249\u2013255","journal-title":"Bone"},{"key":"1497_CR49","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S8756-3282(98)00086-6","volume":"23","author":"T Shimizu","year":"1991","unstructured":"Shimizu T, Mehdi R, Yoshimura Y et al (1991) Sequential expression of bone morphogenetic protein, tumor necrosis factor, and their receptors in bone-forming reaction after mouse femoral marrow ablation. Bone 23:127\u2013133","journal-title":"Bone"},{"issue":"7","key":"1497_CR50","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1359\/jbmr.060410","volume":"21","author":"FH Zhou","year":"2006","unstructured":"Zhou FH, Foster BK, Zhou XF et al (2006) TNF-alpha mediates p38 MAP kinase activation and negatively regulates bone formation at the injured growth plate in rats. J Bone Miner Res 21(7):1075\u20131088","journal-title":"J Bone Miner Res"},{"key":"1497_CR51","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1074\/jbc.275.2.999","volume":"275","author":"G Boguslawski","year":"2000","unstructured":"Boguslawski G, Hale LV, Yu XP et al (2000) Activation of osteocalcin transcription involves interaction of protein kinase A and protein kinase C dependent pathways. J Biol Chem 275:999\u20131000","journal-title":"J Biol Chem"}],"container-title":["International Orthopaedics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00264-012-1497-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00264-012-1497-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00264-012-1497-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T16:33:10Z","timestamp":1686760390000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00264-012-1497-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,14]]},"references-count":51,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["1497"],"URL":"https:\/\/doi.org\/10.1007\/s00264-012-1497-6","relation":{},"ISSN":["0341-2695","1432-5195"],"issn-type":[{"value":"0341-2695","type":"print"},{"value":"1432-5195","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,14]]}}}